SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
47491/11/2007 XTNT Biotech XTENT announces terms XTENT, which is developing a treatmsjemmeri1/12/2007
4748You'll have better luck with that question over here: Subject 26145 A few tuck1/11/2007
4747Any views of Sangamo (SGMO) and their partnerships/technology?atldad1/11/2007
4746BVF moves of last three months. EDGAR has changed its format of late, and the stuck12/28/2006
4745Tuck, Just speculating but I also think there could be a storage issue. If eacrkrw12/26/2006
4744Starting to look at this one. Burn less of an issue now that they've financtuck12/26/2006
474312/19/2006 OREX Biotech Orexigen files for IPO Orexigen, which is developing tresjemmeri12/20/2006
4742Somewhat OT: Doc Praveen, I know of two firms that think Amgen will win the catuck12/19/2006
4741Hematide may have a dosing adv of once per month as compared to Amgen's Epo dr.praveen12/18/2006
4740Thanks Tuck..eomzeta196112/15/2006
4739Affymax' website succinctly summarizes Hematide's advantages over EPO hetuck12/15/2006
4738Doc..do you know anything about AFFY's epo agent?..esp. compared to Amgenzeta196112/15/2006
4737Make it 31$ tuck...400M plus if I am right:-)dr.praveen12/15/2006
4736>>Affymax Prices IPO Ahead of Range Friday December 15, 10:33 am ET Affymatuck12/15/2006
473512/5/2006 IMRX Biotech ImaRx Therapeutics withdraws IPO ImaRx Therapeutics, whicsjemmeri12/7/2006
4734Kalypsys Raises $100 Million in a Series C Financing Wednesday November 29, 8:00nigel bates11/29/2006
473311/28/2006 AZMA Biotech Asthmatx withdraws IPO Asthmatx, which is developing a sjemmeri11/29/2006
4732Organon IPO on track despite Pfizer pullout-Akzo AMSTERDAM, Nov 28 (Reuters) - nigel bates11/28/2006
4731nudge, nudge..... Happy Thanksgiving, all! Rickscaram(o)uche11/22/2006
4730Synta...Help..Push me out of the gate :-) Synta files $115M IPO Perhaps buoyeddr.praveen11/22/2006
4729EBS Emergent BioSolutions prices at $12.50 Emergent BioSolutions, which develosjemmeri11/15/2006
472811/9/2006 OPTR Biotech Optimer Pharmaceuticals files for IPO Optimer Pharmaceutsjemmeri11/10/2006
472711/8/2006 CPRX Catalyst Pharmaceutical Partners prices shares at $6 Catalyst Phsjemmeri11/8/2006
4726Despite biotech takeovers, market still not liking IPOs as 2 more price below rasjemmeri10/26/2006
472510/24/2006 EBSI Biotech Emergent Biosolutions sets terms Emergent Biosolutions, sjemmeri10/25/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News